Skip to content
What We Do
For Providers
Model-Informed Precision Dosing
Clinical Decision Support
Real-Time Clinical Analytics
Infectious Disease
Bone Marrow Transplant
Other Therapeutic Areas
Customers
For Life Sciences
Precision Dosing in Clinical Trials
Real-time Pharmacology Analytics in Clinical Trials
Companion Applications
How We Do It
InsightRX Nova
InsightRX Apollo
Continuous Learning
Integrations
Drug Modules
Security
Company
Mission & Values
Leadership
Careers
Press Releases
Press Releases
Media
Resources
Product Innovation
Scientific Publications
Thought Leadership
White Papers
Contact Us
FEATURED
Choosing the right model for your patient: An introduction to InsightRX Gemini
Resources
Scientific Publications
Jan 10, 2025
Comparing two-sample log-linear exposure estimation with Bayesian model-informed precision dosing of tobramycin in adult patients with cystic fibrosis
Thought Leadership
Dec 26, 2024
How are pharmacokinetic models selected for InsightRX Nova?
Thought Leadership
Dec 3, 2024
NCA vs. MAP Bayesian estimation for dose adjustment of busulfan and other medications
Thought Leadership
Nov 6, 2024
Heparin: the puppy who won’t sit still
Scientific Publications
Oct 9, 2024
Impacts of age and BMI on vancomycin model choice in a Bayesian software: Lessons from a very large multi-site retrospective study
Thought Leadership
Oct 4, 2024
Understanding Model-Informed Precision Dosing (MIPD) and Bayesian Statistics in Pharmacy
Thought Leadership
Sep 18, 2024
How well do AUC24 estimates and trough estimates correlate in vancomycin?
Thought Leadership
Sep 18, 2024
Overcoming barriers to beta-lactam TDM through Bayesian model-informed precision dosing
Thought Leadership
Sep 11, 2024
Choosing the right model for your patient: An introduction to InsightRX Gemini
1
2
3
4
5
